India is proudly known as the Pharmacy of the World, and rightly so.
Our country supplies over 20% of the world’s generic medicines and fulfils nearly 60% of the global vaccine demand. During the COVID-19 pandemic, when the world was struggling, India stepped forward as a lifeline by manufacturing and supplying vaccines and essential medicines to countries across the globe. This demonstrated not only our manufacturing strength but also our commitment to global healthcare.
India’s pharmaceutical industry has earned this title because of three major strengths: affordability, scale, and trust.
First, affordability. Medicines manufactured in India are cost-effective, making life-saving treatment accessible to millions of people worldwide.
Second, scale. India has one of the largest pharmaceutical manufacturing sectors in the world, with numerous facilities approved by international regulatory authorities such as the US FDA.
Third, trust. Indian pharmaceutical companies have built a global reputation for producing high-quality generic medicines.
These achievements are remarkable. But today, the question before us is:
Should India remain the Pharmacy of the World, or should it become the Next Innovation Hub?
I believe the answer is clear.
India must evolve from being a manufacturing powerhouse to becoming an innovation powerhouse.
Why?
Because manufacturing generic medicines, although essential, often means producing drugs that were originally discovered elsewhere. It gives us volume, but not always value. The true leadership of the pharmaceutical industry lies in innovation by discovering new drugs, developing advanced therapies, and creating breakthrough healthcare technologies.
Imagine an India where we are not only manufacturing affordable medicines but also inventing the next life-saving cancer drug, the next revolutionary vaccine, or the next advanced biologic therapy. That is the future we should strive for.
The good news is that we are capable of achieving it.
India has brilliant scientists, skilled pharmacists, rapidly growing biotechnology startups, and exceptional research talent. Government initiatives such as Make in India, Startup India, and increasing investments in pharmaceutical research and development are creating the right environment. Indian pharmaceutical companies are already moving beyond generic medicines into biosimilars, novel drug delivery systems, biotechnology, precision medicine, artificial intelligence in drug discovery, and advanced pharmaceutical research.
This shows that the transformation has already begun.
However, to truly become the Next Innovation Hub, India must focus on three priorities.
First, invest more in research and development.
Innovation requires patience, sustained funding, and world-class research infrastructure.
Second, strengthen collaboration between academia and industry.
Universities, research institutions, and pharmaceutical companies must work together to transform laboratory research into real-world healthcare solutions.
Third, encourage a culture of innovation.
Young pharmacists, scientists, researchers, and entrepreneurs should be inspired not only to manufacture medicines but also to discover and develop them.
Friends,
Being the Pharmacy of the World is a matter of pride.
Becoming the Next Innovation Hub is a matter of vision.
Today, the world depends on India for affordable medicines.
Tomorrow, the world can depend on India for groundbreaking pharmaceutical innovations, cutting-edge biotechnology, and life-changing healthcare solutions.
So, the future of India’s pharmaceutical sector is not the Pharmacy of the World or the Next Innovation Hub.
It is both.
Because India has the strength to heal the world today and the potential to transform global healthcare tomorrow.
Let us believe in that future.
Let us innovate for that future.
Let India lead the world not only in producing medicines but also in discovering them.
Granthali Deshmukh
Final Year B.Pharm